My watch list
my.bionity.com  
Login  

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Leukemia advance online publication, January 3 2017. doi:10.1038/leu.2016.352

Authors: E J Cheadle, G Lipowska-Bhalla, S J Dovedi, E Fagnano, C Klein, J Honeychurch & T M Illidge

Authors:   E J Cheadle; G Lipowska-Bhalla; S J Dovedi; E Fagnano; C Klein; J Honeychurch; T M Illidge
Journal:   Leukemia
Volume:   aop
edition:   current
Year:   2017
DOI:   10.1038/leu.2016.352
Publication date:   28-Nov-2017
Facts, background information, dossiers
More about Nature Publishing Group
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE